Clinical Trials Browser

Phase 2 × Primary Myelofibrosis × Azacitidine × Clear all

NCT01787487 2025-10-09

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Phase 2 Active not recruiting

Myeloproliferative Disorders, Polycythemia Vera, Primary Myelofibrosis

NCT00569660 2012-08-07

Ph II Study of Azacitidine in Myelofibrosis

Phase 2 Completed

34 enrolled 6 charts

MyeloidOther hematologic neoplasm

Leukemia, Primary Myelofibrosis